Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes-Reference-Cited by-同舟云学术

Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes

Published:2018-10 Issue:10 Volume:24 Page:2056-2064
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

McCurdy Shannon R.,Muth Stephen T.,Tsai Hua-Ling,Symons Heather J.,Huff Carol Ann,Matsui William H.^ORCID,Borrello Ivan,Gladstone Douglas E.,Swinnen Lode J.,Cooke Kenneth R.,Brodsky Robert A.,Bolaños-Meade Javier,Ambinder Richard F.,Varadhan Ravi,Luznik Leo,Jones Richard J.,Bettinot Maria P.,Fuchs Ephraim J.

Funder

National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference25 articles.

1. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide;Luznik;Biol Blood Marrow Transplant,2008

2. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts;Brunstein;Blood,2011

3. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide;McCurdy;Blood,2015

4. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide;McCurdy;Haematologica,2017

5. Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia;Powles;Lancet,1983

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide;Leukemia & Lymphoma;2024-05-06

2. Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor;Bone Marrow Transplantation;2023-12-19

3. Relapse after allogeneic transplantation with post-transplant cyclophosphamide: Shattering myths and evolving insight;Blood Reviews;2023-11

4. Posttransplant cyclophosphamide in HLA-matched and 1-2 allele mismatched peripheral blood stem cell transplantation;2023-09-22

5. How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond;Blood;2023-01-05